Pan-D vs Omez-D: Composition, Uses, Side Effects & Generic Savings
Pan-D contains Pantoprazole (40mg) + Domperidone (30mg SR), providing stronger and longer-lasting 24-hour acid suppression with substantially fewer cytochrome CYP2C19 drug interactions compared to Omez-D (Omeprazole 20mg + Domperidone 10mg). Pan-D is the clinical gold standard for severe erosive GERD and patients taking concurrent cardiac or diabetes medications, while Omez-D is suited for acute mild dyspepsia. Both must be taken strictly 30 to 60 minutes before morning breakfast.
Pan-D
Manufactured by Alkem Laboratories Ltd
Strictly 30 to 60 minutes BEFORE morning breakfast with plain water
Headache, Mild diarrhea or loose stools, Abdominal discomfort, Flatulence, Dry mouth
Omez-D
Manufactured by Dr. Reddy's Laboratories Ltd
Strictly 30 minutes BEFORE morning meal on empty stomach
Nausea, Dry mouth, Mild abdominal cramps, Headache, Dizziness
Key Clinical Differences Between Pan-D and Omez-D
- 1. Active PPI Strength & Potency: Pan-D delivers 40mg of Pantoprazole compared to 20mg Omeprazole in standard Omez-D, ensuring higher daytime and nighttime intragastric pH maintenance.
- 2. Domperidone Release Kinetics: Pan-D features 30mg Sustained Release (SR) Domperidone for round-the-clock prokinetic coverage, preventing nocturnal reflux and regurgitation.
- 3. Cardiovascular & CYP450 Safety: Pantoprazole has lower metabolic affinity for the CYP2C19 enzyme than Omeprazole, making Pan-D substantially safer for patients taking Clopidogrel.
- 4. Formulation Technology: Pan-D utilizes multi-unit enteric pellets designed to survive the harsh gastric acid environment before absorption in the duodenum.
- 5. Price & Cost Savings: Bioequivalent generic Pantoprazole + Domperidone at Jan Aushadhi Kendras costs only ₹22 for 10 capsules compared to ₹199 for branded Pan-D (88% savings).
Pantoprazole 40mg + Domperidone 30mg SR Capsules IP
Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), bioequivalent generic formulations are available at Kendras across India with 100% bioequivalent clinical therapeutic efficacy.
1. Pharmacological Mechanism & Salt Differences
Both Pan-D and Omez-D combine a Proton Pump Inhibitor (PPI) with a dopamine-receptor antagonist prokinetic (Domperidone). The PPI acts by irreversibly binding the H+/K+ ATPase enzyme pumps in the gastric parietal cells, turning off acid secretion at the final enzymatic step. Domperidone acts on the chemoreceptor trigger zone (CTZ) and upper gastrointestinal tract, increasing lower esophageal sphincter (LES) tone and speeding stomach emptying to prevent acid and bile from backing up into the food pipe.
2. Why Pantoprazole is Clinically Preferred for Heart Patients
A critical difference between Pan-D and Omez-D lies in their hepatic metabolism. Omeprazole strongly inhibits the cytochrome CYP2C19 liver enzyme, which is required to convert the cardiac drug Clopidogrel into its active blood-thinning form. Taking Omeprazole with Clopidogrel can reduce cardiac protection and increase the risk of stent thrombosis or recurrent heart attacks. Pantoprazole exhibits minimal CYP2C19 inhibition and is the preferred PPI recommended by cardiologists worldwide for patients on dual antiplatelet therapy.
3. How & When to Take: The 30-Minute Empty Stomach Rule
Both Pan-D and Omez-D MUST be swallowed whole with water 30 to 60 minutes BEFORE morning breakfast. Food intake triggers gastric parietal cells to insert thousands of active acid pumps into the secretory canaliculus. The PPI must be present in the bloodstream at peak concentration right when these pumps activate. Taking these medications with food or after meals cuts their therapeutic acid-suppressing efficiency by more than 50%. Never crush, chew, or open the capsules.
4. Long-Term Safety Warnings & Domperidone Monitoring
Domperidone carries a known clinical risk of prolonging the cardiac QT interval when taken in excessive doses or in patients over 60 years with pre-existing heart rhythm abnormalities. It should not be combined with QT-prolonging antibiotics (e.g. erythromycin, clarithromycin) or systemic antifungals. Furthermore, continuous unmonitored PPI use for over 12 months can impair intestinal absorption of calcium, magnesium, and Vitamin B12, increasing bone fracture risk in postmenopausal women.
Comprehensive Clinical Pharmacology & Decision Guide: Pan-D vs Omez-D
When evaluating Pan-D (Pantoprazole Sodium 40mg + Domperidone 30mg SR) against Omez-D (Omeprazole 20mg + Domperidone 10mg (or 30mg SR)), clinicians consider multiple pharmacological parameters including receptor specificity, pharmacokinetic bioavailability, metabolic clearance routes, and potential adverse reactions. The following clinical analysis provides an evidence-based comparison grounded in Indian Pharmacopoeia (IP), National Formulary of India (NFI), and CDSCO regulatory standards.
1. Comparative Mechanism of Action
Pan-D exerts its therapeutic effect through the active pharmaceutical compound Pantoprazole Sodium 40mg + Domperidone 30mg SR, targeting specific enzyme or receptor pathways to relieve indicated clinical symptoms. In contrast, Omez-D utilizes Omeprazole 20mg + Domperidone 10mg (or 30mg SR), which may offer differing therapeutic onset latency, peak plasma concentration, or duration of clinical efficacy depending on patient receptor responsiveness.
2. Pharmacokinetic ADME Profile
Absorption, distribution, metabolism, and excretion (ADME) profiles govern clinical outcomes. Both Pan-D and Omez-D undergo hepatic or renal clearance. Plasma protein binding and elimination half-life ($t_{1/2}$) determine the optimal dosing frequency (e.g., once daily OD vs twice daily BD). Patients with hepatic or renal impairment may require dosage adjustments or increased monitoring.
3. Organ Impairment & High-Risk Precautions
Safety margins differ across patient sub-populations. For patients with reduced estimated Glomerular Filtration Rate (eGFR < 60 mL/min/1.73m²), renal dosage modification may be essential. In hepatic dysfunction (elevated ALT/AST or bilirubin), medications metabolized via Cytochrome P450 enzymes necessitate lower daily thresholds or alternative therapeutic selection.
4. Food & Beverage Interactions
Administration timing relative to meals (empty stomach AC vs post-meal PC) influences gastric tolerance and intestinal absorption. High-fat diets can delay or enhance the absorption of certain lipophilic active salts. Concomitant alcohol consumption must be avoided where hepatotoxicity or central nervous system depression risks exist.
5. Government-Certified Bioequivalent Generic Substitution (PMBJP)
Under the Government of India's Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), bioequivalent generic formulations are produced in WHO-GMP certified facilities with batch-wise NABL testing. Whether opting for Pan-D, Omez-D, or an approved Jan Aushadhi generic alternative of identical active salt, clinical bioequivalence ensures identical therapeutic outcomes while reducing prescription costs by up to 90%. Always consult your treating physician or registered pharmacist before switching formulations.
6. Clinical Decision Checklist Before Choosing Between Pan-D and Omez-D
- Verify whether your prescription specifies the exact brand or the active salt (Pantoprazole Sodium 40mg + Domperidone 30mg SR or Omeprazole 20mg + Domperidone 10mg (or 30mg SR)).
- Check for underlying medical conditions including hypertension, diabetes, peptic ulcers, or renal/hepatic impairment.
- Confirm whether you are taking concurrent medications that share Cytochrome P450 metabolic pathways.
- Ensure dosage strengths match precisely (e.g., tablet mg strength, sustained-release vs immediate-release formulation).
- Store medications in a cool, dry place below 25°C away from direct sunlight and out of reach of children.
Frequently Asked Questions: Pan-D vs Omez-D
Q: Which is better for severe acidity: Pan-D or Omez-D?
Pan-D is generally considered superior for severe erosive GERD and frequent acid regurgitation because 40mg Pantoprazole provides more stable 24-hour acid suppression and fewer cytochrome P450 drug interactions than 20mg Omeprazole in Omez-D.
Q: Can I take Pan-D and Omez-D together?
No, never combine Pan-D and Omez-D. Taking two Proton Pump Inhibitors simultaneously provides zero additional relief and significantly increases the risk of severe side effects like hypomagnesemia, loose stools, and cardiac arrhythmias.
Q: Can Pan-D be taken twice daily?
Standard dosing is one capsule once daily in the morning before breakfast. In severe cases of refractory reflux or acute peptic ulceration, a gastroenterologist may prescribe a second dose 30 minutes before dinner for a brief 14-day period.
Q: What is the PMBJP Jan Aushadhi generic alternative for Pan-D?
The government-certified generic alternative is Pantoprazole 40mg + Domperidone 30mg SR Capsule IP, available at Jan Aushadhi Kendras for ₹22 per strip of 10 capsules—saving up to 88% compared to branded Pan-D (~₹199 for 15 capsules).
Scan & Compare Any Medicine Pair on MediMatch AI
Use our real-time clinical vision scanner to verify active ingredients, identify dangerous food interactions, and calculate Jan Aushadhi generic savings.
Launch Real-Time Drug Comparator